SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022890
Filing Date
2022-08-15
Accepted
2022-08-15 16:17:03
Documents
80
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 907989
2 ex31-1.htm EX-31.1 17559
3 ex31-2.htm EX-31.2 17828
4 ex32.htm EX-32 11295
  Complete submission text file 0001493152-22-022890.txt   5655817

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE invo-20220630.xsd EX-101.SCH 53176
6 XBRL CALCULATION FILE invo-20220630_cal.xml EX-101.CAL 62117
7 XBRL DEFINITION FILE invo-20220630_def.xml EX-101.DEF 202839
8 XBRL LABEL FILE invo-20220630_lab.xml EX-101.LAB 431839
9 XBRL PRESENTATION FILE invo-20220630_pre.xml EX-101.PRE 337455
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 803921
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39701 | Film No.: 221165842
SIC: 3841 Surgical & Medical Instruments & Apparatus